Abstract
Exposure to radiation and some chemotherapeutic agents is associated with an increased risk of developing second cancers. Short telomeres are almost universally associated with malignant cancer progression. An unanswered question is whether inherited short telomeres or therapy-related telomere shortening is a biomarker of the development of second malignant neoplasms. © 2014 American Association for Cancer Research.
Cite
CITATION STYLE
APA
Shay, J. W. (2014). Are short telomeres hallmarks of cancer recurrence? Clinical Cancer Research, 20(4), 779–781. https://doi.org/10.1158/1078-0432.CCR-13-3198
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.
Already have an account? Sign in
Sign up for free